bioRxiv Science⌕ Search

Biology subjects

Vandamme, C.

Publications and source records attributed to Vandamme, C..

2 recordsLinked to original sources

Measured and modelled transitions between self-paced walking and synchronization with rhythmic auditory cues

Constraining gait rhythm with a metronome has been shown to influence gait pattern in many different ways. While rhythmic cues can improve several parameters in some clinical populations, they do alter the long-range autocorrelations naturally exhibited in series of stride durations. However, transitions between walking with and without a metronome (and vice versa) have not been measured; it is therefore unclear how people adapt to such a change in task. To address this gap, a total of 21 healthy volunteers were asked to walk overground under three conditions: one unconstrained control condition, followed by two conditions in which a metronome was activated during either the first or second half of the trial to test both transitions. The long-range autocorrelations were assessed over a sliding window on the stride series to measure their evolution. Our observations were reproduced with a computational model allowing us to relate sudden changes in movement parameters to the long-range autocorrelations, which are typically measured over longer timescales. The results showed a clear transition in both conditions involving a metronome, with long-range autocorrelations of the series of stride durations gradually reduced when the metronome was turned on and recovered when it was turned off. In these two conditions, the change in long-range autocorrelations could be reproduced in the model by an instantaneous switching of the control policy associated with the presence or not of the metronome, suggesting that long-range autocorrelations emerge from a flexible control strategy that rapidly regulates timing and amplitude parameters according to task requirements. Significant statementThrough an experiment involving transitions between walking with and without a metronome, we studied how people adapt to such a change of task by measuring the evolution of long-range autocorrelations (LRA) in the stride series. The results were reproduced in a model by an instantaneous change in the control policy, which validates the hypothesis that LRA emerge from a flexible control that rapidly regulates timing and amplitude parameters according to task requirements.

neuroscience↗

Prevalence study of cellular capsid-specific immune responses to AAV1, 2, 4, 5, 8, 9 and rh10 reveals particular features for AAV9

Recombinant adeno-associated virus (rAAV) vectors appear, more than ever, to be efficient viral vectors for in vivo gene transfer as illustrated by the approvals of 7 drugs across Europe and the USA. Nevertheless, pre-existing immunity to AAV capsid in humans remains one of the major limits for a successful clinical translation. Whereas pre-existing humoral response to AAV capsid is well documented, the prevalence of pre-existing capsid-specific T cell responses still needs to be studied and characterized. Here, we investigated the prevalence of AAV-specific circulating T cells towards AAV2, 4, 5, 8, 9 and rh10 in a large cohort of healthy donors using the standard IFN{gamma} ELISpot assay. We observed the highest prevalence of pre-existing cellular immunity to AAV9 serotype followed by AAV8, AAV4, AAV2, AAVrh10 and AAV5 independently of the donors serological status. An in-depth analysis of T cell responses towards the 2 most prevalent serotypes 8 and 9 shows that IFN{gamma} secretion is mainly mediated by CD8 T cells for both serotypes. A polyfunctional analysis reveals different cytokine profiles between AAV8 and AAV9. Surprisingly, no IL-2 secretion was mediated by anti-AAV9 immune cells suggesting that these cells may rather be exhausted or terminally differentiated than cytotoxic T cells. Altogether, these results suggest that pre-existing immunity to AAV may vary depending on the serotype and support the necessity of using multiparametric monitoring methods to better characterize anti-capsid cellular immunity and foresee its impact in rAAV-mediated clinical trials.

immunology↗